Lauren Zuga
Women's Health · Warren, OHNPI 1063995405
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Myovant Sciences Inc. at 52.1% of the total. Reporting peaked in 2022 at $3,628 and has fallen 85.1% since, to $541 in 2025. Among women's health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $36.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myovant Sciences Inc.$3K
- Astellas Pharma US Inc$575
- Mayne Pharma Commercial LLC$386
- AbbVie$319
- Biohaven Pharmaceutical Holding Company Ltd.$181
- Pfizer$175
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$1,65029%
- Travel & lodging$1,07419%
- Food & beverage$2,64247%
- Education$2524%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myovant Sciences Inc. | 14 | $2,927 |
| Astellas Pharma US Inc | 16 | $575 |
| Mayne Pharma Commercial LLC | 34 | $386 |
| AbbVie | 20 | $319 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $181 |
| Pfizer | 9 | $175 |
| Sage Therapeutics, LLC | 7 | $151 |
| Agile Therapeutics, Inc. | 7 | $136 |
| Exeltis, USA Inc. | 7 | $134 |
| Organon | 8 | $126 |
| Sumitomo Pharma America, Inc. | 5 | $116 |
| Aspira Women's Health Inc | 3 | $63 |
| Therapeuticsmd, Inc. | 3 | $47 |
| Hologic Sales And Service, LLC | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Bayer | 2 | $40 |
| Evofem Biosciences, Inc. | 2 | $35 |
| Smith+Nephew | 1 | $26 |
| Mylan Pharmaceuticals Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $22 |
| Millicent US Inc | 1 | $19 |
| Lupin Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$1,074
- NURTEC ODT$125
- Veozah$125
How this compares
$5,618 in reported general payments places this provider in the 95th percentile of 333 women's health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $1,740 |
| ValacyclovirValacyclovir Hcl | 13 | $722 |
Paid to pharmacies, not to this prescriber.
Other women's health in Warren
- Carrie BlissenbachWarren$3K
- Courtney ArnFranklin$195K
- Carrie van ZantBrookville$21K
- Cindy FarinaCleveland$10K
- Kathryn Lowry-CollinsLebanon$9K
- Angalesia RuckerCleveland$9K
- Vivian RuszkiewiczColumbus$6K
- Lisa LeeseOregon$5K
- Carrie BottiggiMayfield Heights$5K
- Tammy LawsonZanesville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.